
Look into a broad patent push to lock down muscle-preservation approaches as companions to GLP-1 and obesity medicines.
Key Takeaways
- Filings focus on preserving lean muscle mass in people undergoing weight-loss treatment
- But as the market matured, another conversation began to emerge
- Some of that weight can come from lean muscle tissue – the very tissue that helps us move
